Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Neuronetics, Inc.STIM · Entity 6248 | EVP, CLO and CS | March 19, 2026 | March 24, 2026 |
| U.S. SILICA HOLDINGS, INC.SLCA · Entity 88569 | SVP General Counsel | November 08, 2019 | November 12, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Neuronetics, Inc.
Report date March 19, 2026 · Filed March 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 897,270 |
Reported balance
After 2026-03-19 transaction · row 1
1 source rowRow 1 · 2026-03-19 · Sale · Disposed 16,005 · Balance 897,270 F1: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a performance restricted stock unit award. F2: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.48 to $1.20. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a performance restricted stock unit award.
F2: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.48 to $1.20. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
U.S. SILICA HOLDINGS, INC.
Report date November 08, 2019 · Filed November 12, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 43,738 |
Reported balance
After 2019-11-08 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2019-11-08 · Exercise / conversion · Acquired 6,945 · Balance 43,738 F1: Includes 36,793 Restricted Stock Units granted on February 12, 2019 which will vest in three equal installments on the anniversaries of the grant date. |
| Common StockSEC Table I · non-derivative | Direct | 41,006 |
Reported balance
After 2019-11-08 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2019-11-08 · Tax withholding · Disposed 2,732 · Balance 41,006 |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 13,888 |
Reported balance
After 2019-11-08 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-11-08 · Exercise / conversion · Disposed 6,945 · Balance 13,888 F2: Each restricted stock unit represents the right to receive, at settlement, one (1) share of common stock. F3: The restricted stock units were granted November 8, 2018 and vest 1/3 on each of November 8, 2019, November 8, 2020 and November 8, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 36,793 Restricted Stock Units granted on February 12, 2019 which will vest in three equal installments on the anniversaries of the grant date.
F2: Each restricted stock unit represents the right to receive, at settlement, one (1) share of common stock.
F3: The restricted stock units were granted November 8, 2018 and vest 1/3 on each of November 8, 2019, November 8, 2020 and November 8, 2021.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 19, 2026 Filed Mar 24, 2026 21:48 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 16,005 | $1.34 | $21,446.70 |
DisclosureSEC source: 0001193125-26-122290 · ownership.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, CLO and CS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 897,270 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a performance restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.48 to $1.20. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 17, 2026 Filed Mar 18, 2026 20:34 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 33,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-114114 · ownership.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, CLO and CS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 913,275 F1 · price: Common stock received for no consideration upon the satisfaction of performance criteria underlying an award of performance based restricted stock units. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:29 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 609 | $1.34 | $816.06 |
DisclosureSEC source: 0001193125-26-096629 · ownership.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, CLO and CS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 879,525 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.39 to $1.28. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:34 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 3,427 | $1.35 | $4,626.45 |
DisclosureSEC source: 0001193125-26-082878 · ownership.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, CLO and CS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 880,134 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.38 to $1.31. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 21:30 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 210,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-071773 · ownership.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, CLO and CS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 883,561 F1 · shares: Represents a restricted stock unit ("RSU") award that vests in three equal annual installments beginning on February 23, 2027, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 22:42 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 14,120 | $1.65 | $23,298.00 |
DisclosureSEC source: 0001193125-26-057538 · ownership.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, CLO and CS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 673,561 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.56 to $1.72. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:32 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 3,485 | $1.55 | $5,401.75 |
DisclosureSEC source: 0001193125-26-048851 · ownership.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, CLO and CS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 687,681 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.45 to $1.60. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 30, 2025 Filed Dec 31, 2025 22:05 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 164,361 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-338393 · ownership.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, GC, CCO and CS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 691,166 F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (i) June 30, 2027 and (ii) the termination of Mr. Macan's employment from the Issuer without cause. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 22:00 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 377 | $4.48 | $1,688.96 |
DisclosureSEC source: 0000950170-25-034868 · ownership.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, GC, CCO and CS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 526,805 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $4.72 to $4.32. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 22:48 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantPerformance Restricted Stock Unit · Derivative | 78,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-028006 · ownership.xml · derivative · entry 2 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, GC, CCO and CS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,750 Underlying: Common Stock · 78,750 shares Expires 2028-07-01 F3 · derivative.exercise_price: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's common stock. F4 · shares: Represents a PRSU award granted on February 24, 2025 and vesting in 1/3 tranches on December 31, 2027, 2026 and 2027, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The Reporting Person receives a percentage of each vesting if the Issuer's year-end cash balance is between 80% and 110% of the target for each fiscal year ending December 31, 2025, 2026 and 2027. F3 · price: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: Represents a PRSU award granted on February 24, 2025 and vesting in 1/3 tranches on December 31, 2027, 2026 and 2027, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The Reporting Person receives a percentage of each vesting if the Issuer's year-end cash balance is between 80% and 110% of the target for each fiscal year ending December 31, 2025, 2026 and 2027. F4 · derivative.expiration_date: Represents a PRSU award granted on February 24, 2025 and vesting in 1/3 tranches on December 31, 2027, 2026 and 2027, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The Reporting Person receives a percentage of each vesting if the Issuer's year-end cash balance is between 80% and 110% of the target for each fiscal year ending December 31, 2025, 2026 and 2027. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 22:48 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 157,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-028006 · ownership.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, GC, CCO and CS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 527,182 F1 · shares: Represents a restricted stock unit ("RSU") award that vests in three equal annual installments beginning on February 24, 2026, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 24, 2025 Filed Mar 13, 2025 21:24 UTC Amendment | Neuronetics, Inc. STIM · Entity 6248 | GrantPerformance Restricted Stock Unit · Derivative | 78,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-038901 · ownership.xml · derivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, GC, CCO and CS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,750 Underlying: Common Stock · 78,750 shares Expires 2028-07-01 F1 · shares: The Form 4 filed on February 26, 2025 inadvertently reported that the performance restricted stock unit ("PRSU") award granted on February 24, 2025 vests in 1/3 tranches on December 31, 2027, 2026 and 2027, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The correct vesting dates are December 31, 2025, 2026 and 2027. The Form 4 also reported that the Reporting Person receives a percentage of each vesting if the Issuer's year-end cash balance is between 80% (the "Threshold Achievement") and 110% of the target for each vesting year. However, the correct Threshold Achievement is 90%. The number of shares reflected in column 7 assumes the maximum potential vest in each vesting year. F1 · derivative.exercise_date: The Form 4 filed on February 26, 2025 inadvertently reported that the performance restricted stock unit ("PRSU") award granted on February 24, 2025 vests in 1/3 tranches on December 31, 2027, 2026 and 2027, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The correct vesting dates are December 31, 2025, 2026 and 2027. The Form 4 also reported that the Reporting Person receives a percentage of each vesting if the Issuer's year-end cash balance is between 80% (the "Threshold Achievement") and 110% of the target for each vesting year. However, the correct Threshold Achievement is 90%. The number of shares reflected in column 7 assumes the maximum potential vest in each vesting year. F1 · derivative.expiration_date: The Form 4 filed on February 26, 2025 inadvertently reported that the performance restricted stock unit ("PRSU") award granted on February 24, 2025 vests in 1/3 tranches on December 31, 2027, 2026 and 2027, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The correct vesting dates are December 31, 2025, 2026 and 2027. The Form 4 also reported that the Reporting Person receives a percentage of each vesting if the Issuer's year-end cash balance is between 80% (the "Threshold Achievement") and 110% of the target for each vesting year. However, the correct Threshold Achievement is 90%. The number of shares reflected in column 7 assumes the maximum potential vest in each vesting year. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 22:03 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 18,965 | $4.11 | $77,946.15 |
DisclosureSEC source: 0000950170-25-022433 · ownership.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, GC, CCO and CS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 369,682 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.99 to $4.27. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 22:00 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 12,175 | $3.83 | $46,630.25 |
DisclosureSEC source: 0000950170-25-021391 · ownership.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, GC, CCO and CS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 388,647 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.74 to $3.96. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 22:05 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 1,970 | $3.28 | $6,461.60 |
DisclosureSEC source: 0000950170-25-018969 · ownership.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, GC, CCO and CS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 400,822 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.51 to $3.95. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 10, 2024 Filed Dec 12, 2024 22:00 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantPerformance Restricted Stock Unit · Derivative | 135,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-135874 · ownership.xml · derivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, GC, CCO and CS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,000 Underlying: Common Stock · 135,000 shares Expires 2025-12-31 F1 · derivative.exercise_price: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: Represents a PRSU award granted on December 10, 2024 and vesting on December 31, 2025, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The performance metrics are as follows: (i) 25% of the award will be attained if the Issuer achieves Cash Flow Breakeven (as defined in the applicable PRSU grant notice) for the fiscal quarter ended June 30, 2025; (ii) 50% of the award will be attained if the Issuer achieves Cash Flow Breakeven for the fiscal quarter ended September 30, 2025 and (iii) 25% of the award will be attained if the Issuer achieves Cash Flow Breakeven for the fiscal quarter ended December 31, 2025. F1 · price: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: Represents a PRSU award granted on December 10, 2024 and vesting on December 31, 2025, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The performance metrics are as follows: (i) 25% of the award will be attained if the Issuer achieves Cash Flow Breakeven (as defined in the applicable PRSU grant notice) for the fiscal quarter ended June 30, 2025; (ii) 50% of the award will be attained if the Issuer achieves Cash Flow Breakeven for the fiscal quarter ended September 30, 2025 and (iii) 25% of the award will be attained if the Issuer achieves Cash Flow Breakeven for the fiscal quarter ended December 31, 2025. F2 · derivative.expiration_date: Represents a PRSU award granted on December 10, 2024 and vesting on December 31, 2025, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The performance metrics are as follows: (i) 25% of the award will be attained if the Issuer achieves Cash Flow Breakeven (as defined in the applicable PRSU grant notice) for the fiscal quarter ended June 30, 2025; (ii) 50% of the award will be attained if the Issuer achieves Cash Flow Breakeven for the fiscal quarter ended September 30, 2025 and (iii) 25% of the award will be attained if the Issuer achieves Cash Flow Breakeven for the fiscal quarter ended December 31, 2025. Read SEC document |
| October 08, 2024 Filed Oct 10, 2024 21:05 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 1,541 | $0.82 | $1,263.62 |
DisclosureSEC source: 0000950170-24-114102 · ownership.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, GC, CCO and CS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 402,792 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $0.78 to $0.83. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 29, 2024 Filed Mar 1, 2024 22:02 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-024006 · ownership.xml · nonDerivative · entry 3 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, GC, CCO and CS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 404,333 F4 · shares: Represents a RSU award that vests in three equal annual installments beginning on February 28, 2025, in each case subject to continuous service of the Reporting Person through such date. F5 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 29, 2024 Filed Mar 1, 2024 22:02 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 6,026 | $2.94 | $17,716.44 |
DisclosureSEC source: 0000950170-24-024006 · ownership.xml · nonDerivative · entry 2 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, GC, CCO and CS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 389,333 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit ("RSU") award. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $2.77 to $3.14. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 22:02 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 22,377 | $3.16 | $70,711.32 |
DisclosureSEC source: 0000950170-24-024006 · ownership.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, GC, CCO and CS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 395,359 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit ("RSU") award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $2.95 to $3.31. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 22:11 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 15,621 | $3.38 | $52,798.98 |
DisclosureSEC source: 0000950170-24-016536 · ownership.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, GC, CCO and CS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 417,736 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.26 to $3.50. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 06, 2024 Filed Feb 7, 2024 22:42 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 5,385 | $3.39 | $18,255.15 |
DisclosureSEC source: 0001209191-24-002958 · doc4.xml · nonDerivative · entry 2 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, GC, CCO and CS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 433,357 F3 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a RSU award. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.22 to $3.51. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 22:42 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 90,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-002958 · doc4.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, GC, CCO and CS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 438,742 F1 · shares: Represents a restricted stock unit ("RSU") award that vests in three equal annual installments beginning on February 5, 2025, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| December 21, 2023 Filed Dec 22, 2023 00:42 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 11,663 | $2.52 | $29,390.76 |
DisclosureSEC source: 0001062993-23-023059 · form4.xml · nonDerivative · entry 3 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, GC, CCO and CS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 348,742 F1 · shares: The sales reported in this Form 4 were pursuant to a 10b5-1 plan validly adopted by the reporting person on on August 28, 2023. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $2.46 to $2.61. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 20, 2023 Filed Dec 22, 2023 00:42 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 11,664 | $2.70 | $31,492.80 |
DisclosureSEC source: 0001062993-23-023059 · form4.xml · nonDerivative · entry 2 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, GC, CCO and CS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 360,405 F1 · shares: The sales reported in this Form 4 were pursuant to a 10b5-1 plan validly adopted by the reporting person on on August 28, 2023. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $2.42 to $2.90. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 19, 2023 Filed Dec 22, 2023 00:42 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 11,664 | $2.24 | $26,127.36 |
DisclosureSEC source: 0001062993-23-023059 · form4.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, GC, CCO and CS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 372,069 F1 · shares: The sales reported in this Form 4 were pursuant to a 10b5-1 plan validly adopted by the reporting person on on August 28, 2023. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $2.13 to $2.50. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 06, 2023 Filed Oct 10, 2023 21:12 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 1,469 | $1.16 | $1,696.70 |
DisclosureSEC source: 0001062993-23-019211 · form4.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, GC, CCO and CS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 383,733 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.10 to $1.16. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 11, 2023 Filed Jul 13, 2023 00:35 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 2,645 | $2.13 | $5,633.85 |
DisclosureSEC source: 0001062993-23-014852 · form4.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, GC, CCO and CS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 385,202 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $2.10 to $2.19. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 21:09 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 12,692 | $4.59 | $58,256.28 |
DisclosureSEC source: 0001062993-23-006417 · form4.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, GC, CCO and CS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 387,847 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $4.23 to $4.74. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 16, 2023 Filed Feb 17, 2023 21:45 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 11,044 | $5.91 | $65,270.04 |
DisclosureSEC source: 0001062993-23-004066 · form4.xml · nonDerivative · entry 2 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, GC, CCO and CS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,539 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $5.72 to $6.01. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 21:45 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 11,974 | $5.90 | $70,646.60 |
DisclosureSEC source: 0001062993-23-004066 · form4.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · EVP, GC, CCO and CS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 411,583 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $5.81 to $6.00. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 08, 2023 Filed Feb 9, 2023 22:48 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 90,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-008117 · doc4.xml · nonDerivative · entry 2 MACAN WILLIAM ANDREW · CIK 0001758584 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 423,557 F3 · shares: Represents a restricted stock unit ("RSU") award that vests in three equal annual installments beginning on February 8, 2024, in each case subject to continuous service of the Reporting Person through such date. F4 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 22:48 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 5,162 | $5.99 | $30,920.38 |
DisclosureSEC source: 0001209191-23-008117 · doc4.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333,557 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $5.93 to $6.06. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 23, 2023 Filed Jan 24, 2023 21:09 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 16,046 | $5.96 | $95,634.16 |
DisclosureSEC source: 0001062993-23-001322 · form4.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338,719 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $5.80 to $6.17. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 10, 2022 Filed Oct 11, 2022 21:33 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 76 | $2.82 | $214.32 |
DisclosureSEC source: 0001062993-22-020704 · form4.xml · nonDerivative · entry 2 MACAN WILLIAM ANDREW · CIK 0001758584 · Sr. VP, GC, CCO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,765 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 21:33 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 1,547 | $2.93 | $4,532.71 |
DisclosureSEC source: 0001062993-22-020704 · form4.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · Sr. VP, GC, CCO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,841 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $2.85 to $3.10. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 08, 2022 Filed Jul 11, 2022 20:11 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 2,746 | $3.60 | $9,885.60 |
DisclosureSEC source: 0001062993-22-016219 · form4.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · Sr. VP, GC, CCO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 356,388 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.54 to $3.63. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 08, 2022 Filed Mar 9, 2022 21:31 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 137 | $3.14 | $429.97 |
DisclosureSEC source: 0001062993-22-007174 · form4.xml · nonDerivative · entry 2 MACAN WILLIAM ANDREW · CIK 0001758584 · Sr. VP, GC, CCO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359,134 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 21:31 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 11,489 | $2.85 | $32,729.86 |
DisclosureSEC source: 0001062993-22-007174 · form4.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · Sr. VP, GC, CCO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359,271 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $2.82 to $2.91. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 23:11 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 166,562 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-003825 · form4.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · Sr. VP, GC, CCO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 370,760 F1 · shares: Represents a restricted stock unit ("RSU") award that vests in three equal annual installments beginning on February 9, 2023, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 08, 2022 Filed Feb 9, 2022 21:31 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 15 | $3.27 | $49.05 |
DisclosureSEC source: 0001062993-22-003327 · form4.xml · nonDerivative · entry 2 MACAN WILLIAM ANDREW · CIK 0001758584 · Sr. VP, GC, CCO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,198 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. Read SEC document |
| February 07, 2022 Filed Feb 9, 2022 21:31 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 4,716 | $3.26 | $15,392.55 |
DisclosureSEC source: 0001062993-22-003327 · form4.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · Sr. VP, GC, CCO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,213 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.21 to $3.37. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 24, 2022 Filed Jan 25, 2022 21:38 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 11,562 | $3.52 | $40,698.24 |
DisclosureSEC source: 0001062993-22-001538 · form4.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · Sr. VP, GC, CCO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,929 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.46 to $3.57. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 04, 2021 Filed Oct 6, 2021 21:11 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-009265 · form4.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · Sr. VP, GC, CCO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,491 F1 · shares: Represents a restricted stock unit ("RSU") award that vests in three equal annual installments beginning on October 4, 2022, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| July 08, 2021 Filed Jul 9, 2021 21:41 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 2,591 | $14.61 | $37,859.95 |
DisclosureSEC source: 0001062993-21-006423 · form4.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · Sr. VP, GC, CCO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,491 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $14.51 to $14.73. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 22:03 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 8,537 | $14.65 | $125,067.05 |
DisclosureSEC source: 0000925421-21-000107 · edgar.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · Sr. VP, GC, CCO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,082 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $14.02 to $15.01. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 22:19 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantPerfornance Restricted Stock Unit · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000925421-21-000076 · edgar.xml · derivative · entry 2 MACAN WILLIAM ANDREW · CIK 0001758584 · Sr. VP, GC, CCO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires not disclosed F3 · derivative.exercise_price: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's common stock. The PRSU rights vest upon the Issuer's common stock achieving a 30 day volume weighted average price of $25 per share. F3 · derivative.exercise_date: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's common stock. The PRSU rights vest upon the Issuer's common stock achieving a 30 day volume weighted average price of $25 per share. F3 · derivative.expiration_date: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's common stock. The PRSU rights vest upon the Issuer's common stock achieving a 30 day volume weighted average price of $25 per share. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 22:19 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 33,166 | $0.00 | $0.00 |
DisclosureSEC source: 0000925421-21-000076 · edgar.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · Sr. VP, GC, CCO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,619 F1 · shares: Represents a restricted stock unit ("RSU") award that vests in three equal annual installments beginning on February 3, 2022, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 22, 2021 Filed Jan 26, 2021 02:26 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 12,696 | $21.28 | $270,170.88 |
DisclosureSEC source: 0000925421-21-000051 · edgar.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · Sr. VP, GC, CCO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,453 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 07, 2020 Filed Jul 8, 2020 21:21 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 18,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001192482-20-000613 · edgar.xml · nonDerivative · entry 1 MACAN WILLIAM ANDREW · CIK 0001758584 · Sr. VP, GC, CCO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,149 F1 · shares: Represents a restricted stock unit ("RSU") award that vests in three equal annual installments beginning on July 7, 2021, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.